Risks of proton-pump inhibitors: what every doctor should know. Comment.
Fernández-Fernández
Francisco J
FJ
Pía
Gonzalo
G
Sesma
Pascual
P
D001241:Aspirin / Q000493:pharmacokinetics; D000077144:Clopidogrel; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005744:Gastric Acid / Q000378:metabolism; D005753:Gastric Mucosa / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D010975:Platelet Aggregation Inhibitors / Q000493:pharmacokinetics; D054328:Proton Pump Inhibitors / Q000009:adverse effects* / Q000493:pharmacokinetics; D012307:Risk Factors; D055502:Secondary Prevention; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000493:pharmacokinetics
D010975:Platelet Aggregation Inhibitors; D054328:Proton Pump Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin